Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. 29 Sep Continue reading →
β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice Continue reading →
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway. Continue reading →
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Continue reading →
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues 22 Nov Continue reading →